AI rapidly reshapes medicine—clinically tested AI now outperforms doctors in ERs, discovers new drugs, and sparks a debate on cost, workforce, and ethics.
AI could crack math’s toughest problems by 2054—explore how new reasoning models and $1 M prizes push breakthroughs while reshaping work and creative culture.
Groundbreaking CAR T cell therapy may have cured a 3‑year‑old’s liver cancer in an outpatient setting, but real‑world data are still unverified—read the latest AI‑driven insights and access challenges.
XPENG launches its first automated line to mass‑produce the humanoid “Iron” robot, boosting robotics manufacturing and sparking debate on AI and labor.
Hyderabad’s HyperVault AI campus will house 1‑GW capacity, 264 acres, and Rs 70,000 crore investment, powering high‑density GPU workloads for global AI companies.
Public sentiment on AI and the Singularity is shifting from niche skepticism to mainstream acceptance, yet concerns over power concentration, safety, and open‑source risks remain high.
Balancing AI agent cost and capability: Why developers favor “good enough” models over pricey, high‑reasoning options and how unchecked autonomy threatens corporate control.